Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin (Q40951134)
scientific article published on May 1999
Language:
Current Data About Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin
(P31) (Q13442814)
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P304) 1189-1196
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P407) (Q1860)

(P433) 5
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P478) 5
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P577) Saturday, May 1, 1999
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P921) (Q422327)
(P887)

(P1433) (Q332253)
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P1476) "Cellular pharmacology of the combination of the DNA topoisomerase I inhibitor SN-38 and the diaminocyclohexane platinum derivative oxaliplatin" (language: en)
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

(P2093) N Zeghari-Squalli
(P1545) 1
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

E Raymond
(P1545) 2
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

E Cvitkovic
(P1545) 3
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

F Goldwasser
(P1545) 4
(P248)
(P698) 10353756
(P813) Monday, September 25, 2017

other details
description scientific article published on May 1999

External Links
(P698) 10353756